The impact of multidisciplinary care for locally advanced rectal cancer referrals: A systems perspective.

Authors

Victor Lo

Victor Lo

University of Ottawa, Ottawa, ON, Canada

Victor Lo , Ranjeeta Mallick , Rachel Anne Goodwin , Joanna Gotfrit

Organizations

University of Ottawa, Ottawa, ON, Canada, Ottawa Hospital Research Institute, Ottawa, ON, Canada, The Ottawa Hospital Cancer Centre, Ottawa, ON, Canada

Research Funding

No funding sources reported

Background: Locally advanced rectal cancer patients require multidisciplinary care for treatment planning. We sought to determine whether the order of surgical and radiation oncology consultation in relation to medical oncology consultation affects the time from cancer diagnosis to treatment initiation and the requirement for additional pre-treatment visits with medical oncology. Methods: We conducted a retrospective chart review of adult patients referred to The Ottawa Hospital with locally advanced rectal adenocarcinoma, seen in consultation by a surgical, radiation, and medical oncologist between January 2018 and December 2022. Results: Of 195 patients, the median time from diagnosis to treatment was 55 days (IQR: 45-68). Both surgical and radiation oncology consultation preceded medical oncology consultation in a minority of patients (72; 37%), and 48 (25%) patients required multidisciplinary cancer conference (MCC) discussion. However, the time from cancer diagnosis to treatment initiation was not significantly different between patients who were and were not seen by the surgeon and radiation oncologist prior to the medical oncologist (56 vs. 55 days respectively), nor if MCC discussions were or were not required (55 vs. 55 days). However, almost half of all patients (93; 48%) required an additional pre-treatment visit with their medical oncologist, and patients who saw both surgical and radiation oncology prior were significantly less likely to require additional pre-treatment visits with medical oncology (25% vs. 61%; p<0.0001). Conclusions: The time from cancer diagnosis to treatment initiation was not significantly impacted by the order of specialist consultations with the multidisciplinary team, nor if patients required MCC discussion or additional pre-treatment visits with medical oncology. However additional pre-treatment visits with medical oncology were significantly more likely to occur when patients were seen by medical oncology prior to surgical and/or radiation oncology, representing a logistical and financial inefficiency in the system, and a potential area for process improvement.

No Additional Visits with Med OncOne or More Additional Visits with Med OncProportion of Patients Who Required Additional Visit(s) with Med Oncp
Seen surg onc prior to med onc74 (38%)42 (22%)42/116 (36%)<0.0001
Did not see surg onc prior to med onc28 (14%)51 (26%)51/79 (65%)
Seen rad onc prior to med onc77 (34%)44 (23%)44/121 (26%)<0.0001
Did not see rad onc prior to med onc25 (13%)49 (25%)49/74 (66%)
Seen both surg&rad onc prior to med onc54 (28%)18 (9%)18/72 (25%)<0.0001
Did not see both surg&rad onc prior to med onc48 (25%)75 (38%)75/123 (61%)

surg onc surgical oncologist; rad onc radiation oncologist; med onc medical oncologist.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Abstract Details

Meeting

2024 ASCO Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session C: Cancers of the Colon, Rectum, and Anus

Track

Colorectal Cancer,Anal Cancer

Sub Track

Quality of Care/Quality Improvement

Citation

J Clin Oncol 42, 2024 (suppl 3; abstr 85)

DOI

10.1200/JCO.2024.42.3_suppl.85

Abstract #

85

Poster Bd #

F8

Abstract Disclosures

Similar Abstracts

First Author: Katie Nadine Lee

First Author: Felipe Fernando Quezada

First Author: Kathryn Ries Tringale